A significant breakthrough in cancer research is arising with the use of nanobodies to reactivate dysfunctional p53. This vital cancer inhibitor protein is frequently lost in several forms of cancer, resulting https://push2bookmark.com/story22129555/mini-antibodies-revive-p53-a-potential-pathway-for-malignant-treatment